Aleniglipron Phase 2 Body Composition Study

NCT07169942 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity, Overweight, or Chronic Weight Management

Interventions

DRUG: aleniglipron or placebo

Sponsor

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics